• Something wrong with this record ?

Reductive carboxylation and 2-hydroxyglutarate formation by wild-type IDH2 in breast carcinoma cells

K. Smolková, A. Dvořák, J. Zelenka, L. Vítek, P. Ježek,

. 2015 ; 65 (-) : 125-33. [pub] 20150522

Language English Country Netherlands

Document type Journal Article, Research Support, Non-U.S. Gov't

Mitochondrial NADPH-dependent isocitrate dehydrogenase, IDH2, and cytosolic IDH1, catalyze reductive carboxylation of 2-oxoglutarate. Both idh2 and idh1 monoallelic mutations are harbored in grade 2/3 gliomas, secondary glioblastomas and acute myeloid leukemia. Mutant IDH1/IDH2 enzymes were reported to form an oncometabolite r-2-hydroxyglutarate (2HG), further strengthening malignancy. We quantified CO2-dependent reductive carboxylation glutaminolysis (RCG) and CO2-independent 2HG production in HTB-126 and MDA-MB-231 breast carcinoma cells by measuring (13)C incorporation from 1-(13)C-glutamine into citrate, malate, and 2HG. For HTB-126 cells, (13)C-citrate, (13)C-malate, and (13)C-2-hydroxyglutarate were enriched by 2-, 5-, and 15-fold at 5mM glucose (2-, 2.5-, and 13-fold at 25 mM glucose), respectively, after 6 h. Such enrichment decreased by 6% with IDH1 silencing, but by 30-50% upon IDH2 silencing while cell respiration and ATP levels rose up to 150%. Unlike 2HG production RCG declined at decreasing CO2. At hypoxia (5% O2), IDH2-related and unrelated (13)C-accumulation into citrate and malate increased 1.5-2.5-fold with unchanged IDH2 expression; whereas hypoxic 2HG formation did not. (13)C-2HG originated by ∼50% from other than IDH2 or IDH1 reactions, substantiating remaining activity in IDH1&2-silenced cells. Relatively high basal (12)C-2HG levels existed (5-fold higher vs. non-tumor HTB-125 cells) and (13)C-2HG was formed despite the absence of any idh2 and idh1 mutations in HTB-126 cells. Since RCG is enhanced at hypoxia (frequent in solid tumors) and 2HG can be formed without idh1/2 mutations, we suggest 2HG as an analytic marker (in serum, urine, or biopsies) predicting malignancy of breast cancer in all patients.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16020753
003      
CZ-PrNML
005      
20160805120922.0
007      
ta
008      
160722s2015 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.biocel.2015.05.012 $2 doi
024    7_
$a 10.1016/j.biocel.2015.05.012 $2 doi
035    __
$a (PubMed)26007236
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Smolková, Katarína $u Department of Membrane Transport Biophysics, No.75, Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic. Electronic address: smolkova@biomed.cas.cz.
245    10
$a Reductive carboxylation and 2-hydroxyglutarate formation by wild-type IDH2 in breast carcinoma cells / $c K. Smolková, A. Dvořák, J. Zelenka, L. Vítek, P. Ježek,
520    9_
$a Mitochondrial NADPH-dependent isocitrate dehydrogenase, IDH2, and cytosolic IDH1, catalyze reductive carboxylation of 2-oxoglutarate. Both idh2 and idh1 monoallelic mutations are harbored in grade 2/3 gliomas, secondary glioblastomas and acute myeloid leukemia. Mutant IDH1/IDH2 enzymes were reported to form an oncometabolite r-2-hydroxyglutarate (2HG), further strengthening malignancy. We quantified CO2-dependent reductive carboxylation glutaminolysis (RCG) and CO2-independent 2HG production in HTB-126 and MDA-MB-231 breast carcinoma cells by measuring (13)C incorporation from 1-(13)C-glutamine into citrate, malate, and 2HG. For HTB-126 cells, (13)C-citrate, (13)C-malate, and (13)C-2-hydroxyglutarate were enriched by 2-, 5-, and 15-fold at 5mM glucose (2-, 2.5-, and 13-fold at 25 mM glucose), respectively, after 6 h. Such enrichment decreased by 6% with IDH1 silencing, but by 30-50% upon IDH2 silencing while cell respiration and ATP levels rose up to 150%. Unlike 2HG production RCG declined at decreasing CO2. At hypoxia (5% O2), IDH2-related and unrelated (13)C-accumulation into citrate and malate increased 1.5-2.5-fold with unchanged IDH2 expression; whereas hypoxic 2HG formation did not. (13)C-2HG originated by ∼50% from other than IDH2 or IDH1 reactions, substantiating remaining activity in IDH1&2-silenced cells. Relatively high basal (12)C-2HG levels existed (5-fold higher vs. non-tumor HTB-125 cells) and (13)C-2HG was formed despite the absence of any idh2 and idh1 mutations in HTB-126 cells. Since RCG is enhanced at hypoxia (frequent in solid tumors) and 2HG can be formed without idh1/2 mutations, we suggest 2HG as an analytic marker (in serum, urine, or biopsies) predicting malignancy of breast cancer in all patients.
650    _2
$a nádorové biomarkery $x genetika $x metabolismus $7 D014408
650    _2
$a nádory prsu $x enzymologie $x genetika $x metabolismus $7 D001943
650    _2
$a hypoxie buňky $x fyziologie $7 D015687
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a glutaráty $x metabolismus $7 D005977
650    _2
$a lidé $7 D006801
650    _2
$a isocitrátdehydrogenasa $x genetika $x metabolismus $7 D007521
650    _2
$a kyslík $x metabolismus $7 D010100
650    _2
$a parciální tlak $7 D010313
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Dvořák, Aleš $u Department of Membrane Transport Biophysics, No.75, Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic; Institute of Medical Biochemistry and Laboratory Diagnostics, Department of Internal Medicine, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. Electronic address: ales.dvorak@biomed.cas.cz.
700    1_
$a Zelenka, Jaroslav $u Department of Membrane Transport Biophysics, No.75, Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic. Electronic address: zelenka@biomed.cas.cz.
700    1_
$a Vítek, Libor $u Institute of Medical Biochemistry and Laboratory Diagnostics, Department of Internal Medicine, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. Electronic address: vitek@cesnet.cz.
700    1_
$a Ježek, Petr $u Department of Membrane Transport Biophysics, No.75, Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic. Electronic address: jezek@biomed.cas.cz.
773    0_
$w MED00006475 $t The international journal of biochemistry & cell biology $x 1878-5875 $g Roč. 65, č. - (2015), s. 125-33
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26007236 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160722 $b ABA008
991    __
$a 20160805121155 $b ABA008
999    __
$a ok $b bmc $g 1155423 $s 945281
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 65 $c - $d 125-33 $e 20150522 $i 1878-5875 $m International journal of biochemistry and cell biology $n Int J Biochem Cell Biol $x MED00006475
LZP    __
$a Pubmed-20160722

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...